Magula, N; Dedicoat, M (2015년 1월 28일). “Low dose versus high dose stavudine for treating people with HIV infection.”. 《The Cochrane Database of Systematic Reviews》 1: CD007497. doi:10.1002/14651858.CD007497.pub2. PMID25627012.
Wangsomboonsiri W, Mahasirimongkol S, Chantarangsu S, 외. (2010년 2월 15일). “Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen”. 《Clinical Infectious Diseases》 50 (4): 597–604. doi:10.1086/650003. PMID20073992.
U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332). (2018, April 30). FDA Drug Shortages. Retrieved May 1, 2018, from https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm Drug Shortages&AI=Stavudine Capsules&st=d&tab=tabs-4&panels=0&elqTrackId=ea74e0ed22944bcb80c0e85a7812de68&elq=eba2efb7014449bd94d27eba432bc417&elqaid=3343&elqat=1&elqCampaignId=2529#
Magula, N; Dedicoat, M (2015년 1월 28일). “Low dose versus high dose stavudine for treating people with HIV infection.”. 《The Cochrane Database of Systematic Reviews》 1: CD007497. doi:10.1002/14651858.CD007497.pub2. PMID25627012.
Wangsomboonsiri W, Mahasirimongkol S, Chantarangsu S, 외. (2010년 2월 15일). “Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen”. 《Clinical Infectious Diseases》 50 (4): 597–604. doi:10.1086/650003. PMID20073992.